Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
BI 770371 + Pembrolizumab ± Cetuximab for Head and Neck Cancer
Recruiting1 awardPhase 1
Louisville, Kentucky
This trial is for adults with head and neck cancer. The goal is to see if combining different medications can reduce tumor size in these patients. The medications being tested work in various ways against cancer. Participants
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service